# US 2025/0084082 A1 · Huperzine b crystal and preparation and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084082 A1
- Document ID: US20250084082A1
- Status: Published application
- Kind: A1
- Application number: 18/579,816
- Filed: 2022-07-13
- Published: 2025-03-13
- Earliest claimed: 2021-07-13
- Assignees: Shanghai Tin Tsz Bio Valley Biological Engineering Co., Ltd
- Applicants: Shanghai Tin Tsz Bio Valley Biological Engineering Co., Ltd.
- Inventors: Delong XIE; Wangzhou CHI; Yonggang LI; Xuhua HU; Bo GU; Dongyan SUN; Zhiqiang LIU; Baosheng YIN
- Web page: https://patentgrep.com/patent/US20250084082A1

## CPC

- C07D 471/08: Bridged systems
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention provides a huperzine B crystal and a preparation thereof. Specifically, the present invention provides a crystal form A of the huperzine B crystal. An X-ray diffraction pattern of the crystal form A has the following 2θ angular characteristic absorption peak: 9.56±0.2, 13.90±0.2, 14.88±0.2, 16.00±0.2, 25.39±0.2, and 28.78±0.2.

## Claims

### Claim 1

A crystal form A of Huperzine B, wherein the X-ray diffraction pattern of the crystal form A has characteristic absorption peaks at the following 2θ angular: 9.56±0.2, 13.90±0.2, 14.88±0.2, 16.00±0.2, 25.39±0.2 and 28.78±0.2.

### Claim 2 (depends on 1)

The crystal form of claim 1, wherein the X-ray diffraction pattern of the crystal form further comprises one or more characteristic absorption peaks at 2θ angular selected from the group consisting of: 12.08±0.2, 13.26±0.2, 14.12±0.2, 15.18±0.2, 16.86±0.2, 18.45±0.2, 19.12±0.2, 19.84±0.2, 22.41±0.2, 22.97±0.2, 23.42±0.2, 24.79±0.2, 25.81±0.2, 26.01±0.2, 26.34±0.2, 27.65=0.2, 28.04±0.2, 28.44±0.2, 29.86±0.2, 30.51±0.2, 31.22±0.2, 33.22±0.2, 34.94±0.2, 37.09±0.2 and 38.64=0.2.

### Claim 3 (depends on 1)

The crystal form of claim 1, wherein the infrared spectrum of the crystal form, as measured by KBr compression, has one or more characteristic absorption peaks selected from the group consisting of: 3323.36 cm−1, 3219.52 cm−1, 3088.83 cm−1, 2994.76 cm−1, 2958.33 cm−1, 2938.33 cm−1, 2913.38 cm−1, 2861.67 cm−1, 2817.87 cm−1, 1666.30 cm−1, 1605.50 cm−1, 1555.70 cm−1, 1453.09 cm−1, 1429.96 cm−1, 1369.99 cm−1, 1346.50 cm−1, 1323.03 cm−1, 1309.51 cm−1, 1283.99 cm−1, 1260.62 cm−1, 1200.47 cm−1, 1180.20 cm−1, 1155.23 cm−1, 1127.13 cm−1, 1099.03 cm−1, 1071.87 cm−1, 1055.99 cm−1, 1046.15 cm−1, 993.81 cm−1, 973.82 cm−1, 958.22 cm−1, 915.72 cm−1, 867.03 cm−1, 855.87 cm−1, 839.87 cm−1, 815.10 cm−1, 783.02 cm−1, 755.87 cm−1, 731.69 cm−1, 686.04 cm−1, 651.90 cm−1, 629.38 cm−1, 568.32 cm−1, 521.58 cm−1, 499.42 cm−1, 487.62 cm−1, 467.39 cm−1, 442.58 cm−1, and 417.99 cm−1.

### Claim 4 (depends on 1)

The crystal form of claim 1, wherein the Raman spectrum of the crystal form has one or more characteristic absorption peaks selected from the group consisting of: the absorption peaks were found at 2939.42 cm−1, 2909.62 cm−1, 2879.72 cm−1, 2864.57 cm−1, 2820.5 cm−1, 1674.43 cm−1, 1602.88 cm−1, 1553.75 cm−1, 1450.8 cm−1, 1288.9 cm−1, 1262.33 cm−1, 1246.66 cm−1, 719.965 cm−1 and 683.93 cm−1.

### Claim 5 (depends on 1)

A preparation method of the crystal form of claim 1, wherein the method comprises the steps of:
1) dissolving Huperzine B in a first solvent under the heating conditions to obtain a first solution of Huperzine B;
2) performing following step 2a) or 2b):
2a) cooling down the first solution of Huperzine Band slowly evaporating the solvent to dryness;
2b) cooling down to room temperature to precipitate crystals and standing at about 0° C.;
3. drying the product obtained in step 2) in vacuum and collecting the resulting solid to obtain the crystal form.

### Claim 6 (depends on 5)

The preparation method of claim 5, wherein when step 2a) is employed, in step 1), the first solvent is selected from the group consisting of: methanol, ethanol, n-butanol, 1,4-dioxane, 1,2-dichloroethane, dichloromethane, acetone, water, and combinations thereof.

### Claim 7 (depends on 5)

The preparation method of claim 5, wherein when step 2a) is employed, in step 1), the ratio of solvent to Huperzine B is 1: 15-75 (ml: mg); and/or
in step 1), the heating temperature is 50° C.-90° C.

### Claim 8 (depends on 5)

The preparation method of claim 5, wherein when step 2b) is employed, the first solvent is selected from the group consisting of: ethanol, n-butanol, 1,4-dioxane, 1,2-dichloroethane, N,N-dimethylformamide, acetone, water, methyl tert-butyl ether, and combinations thereof.

### Claim 9 (depends on 5)

The preparation method of claim 5, wherein when step 2b) is employed, in step 1), the ratio of solvent to Huperzine B is 1:15-90 (ml: mg); and/or
in step 1), the heating temperature is 70° C.-90° C.

### Claim 10 (depends on 1)

A preparation method of the crystal form of claim 1, wherein the method comprises the steps of:
i) adding Huperzine B to a second solvent, heating and stirring and keeping for 48-96 hours to obtain a reaction mixture;
ii) placing the reaction mixture in an open container and evaporating the solvent to dryness at room temperature;
iii) drying in vacuum and collecting the resulting solid to obtain the crystal form.

### Claim 11 (depends on 10)

The preparation method of claim 10, wherein the second solvent is selected from the group consisting of: toluene, ethyl acetate, methyl tert-butyl ether, and combinations thereof.

### Claim 12 (depends on 10)

The preparation method of claim 10, wherein in step i), the ratio of solvent to Huperzine B is 1: 2-10 (ml: mg); and/or
in step ii), the heating temperature is 40° C.-60° C.
